*

Analyse
Mine nyheder

Vi har ikke publiceret nogle artikler for nyligt i de emner, du følger. Søg efter andre emner her.

Du har ingen overvågninger endnu

Klik på ikonet for at overvåge
emner og journalister.

0

Brancheanalyse: Novo Nordisk og konkurrenterne

Novo Nordisk er Danmarks mest værdifulde selskab. Kigger man ud i verden, så har det danske medicinalselskab fortsat noget arbejde foran sig, hvis man har en ambition om at nå helt op i toppen over verdens største medicinalselskaber.

Lars Fruergaard Jørgensen har siden årsskiftet stået i spidsen for Novo Nordisk, efter at det i efteråret 2016 blev annonceret, at han var udpeget til at efterfølge Lars Rebien Sørensen. Foto: Novo Nordisk/Presse

Rang 2017

Virksomhed

Rang 2016

Omsætning (1000 kr.)

 Markedsværdi (1000 kr.) 

Nettoresultat (1000 kr.)

Driftresultat (1000 kr.)

                                         1

Roche 

                                         3

                                              349.459

                            1.469.331

                                             67.251

                                      97.211

                                         2

Pfizer 

                                         2

                                              355.495

                            1.425.077

                                             48.556

                                      56.201

                                         3

Novartis 

                                         1

                                              326.517

                            1.400.148

                                             45.076

                                      55.642

                                         4

Merck 

                                         5

                                              267.893

                            1.256.828

                                             38.441

                                      50.467

                                         5

Sanofi 

                                         4

                                              258.639

                               785.930

                                             54.458

                                      69.191

                                         6

GSK 

                                         6

                                              270.259

                               690.212

                                             10.291

                                      25.176

                                         7

Eli Lilly 

                                         8

                                              142.821

                               617.200

                                             18.424

                                      23.277

                                         8

AstraZeneca 

                                         7

                                              206.592

                               497.642

                                             33.907

                                      47.503

                                         9

Novo Nordisk 

                                         9

                                              111.780

                               495.292

                                             37.925

                                      48.432

                                       10

Takeda 

                                       10

                                                98.112

                                      255

                                               4.532

                                        7.102